Sarepta Therapeutics (SRPT) EPS (Diluted) Growth (3y) (2013 - 2026)
Sarepta Therapeutics (SRPT) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.01% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.90% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 61.64% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 36.83% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.99% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -36.81% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.39% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 67.51% |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 44.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.39% |
| Mar 31, 2026 | 35.05% |
| Dec 31, 2025 | -40.12% |
| Sep 30, 2025 | 91.52% |
| Jun 30, 2025 | 26.01% |
| Mar 31, 2025 | 84.37% |
| Dec 31, 2024 | 43.87% |
| Sep 30, 2024 | 26.00% |
| Jun 30, 2024 | 27.39% |
| Mar 31, 2024 | 29.57% |
| Dec 31, 2023 | 30.11% |
| Sep 30, 2023 | 43.12% |
| Jun 30, 2023 | 48.14% |
| Mar 31, 2023 | -194.74% |
| Dec 31, 2022 | 46.97% |
| Sep 30, 2022 | -1,099.79% |
| Jun 30, 2022 | -791.18% |
| Mar 31, 2022 | -940.52% |
| Dec 31, 2021 | 10.89% |
| Sep 30, 2021 | -705.36% |